Naranjo Diana, Tanenbaum Molly L, Iturralde Esti, Hood Korey K
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, CA, USA
Department of Pediatrics, Stanford University School of Medicine, CA, USA.
J Diabetes Sci Technol. 2016 Jun 28;10(4):852-8. doi: 10.1177/1932296816650900. Print 2016 Jul.
Patients managing type 1 diabetes have access to new technologies to assist in management. This manuscript has two aims: 1) to briefly review the literature on diabetes technology use and how this relates to psychological factors and 2) to present an example of human factors research using our data to examine psychological factors associated with technology use. Device/technology uptake and use has increased over the years and at present day is a common clinical practice. There are mixed results in terms of health and psychosocial outcomes, with specific subgroups doing better than others with technology. Our data demonstrated that patients have moderately elevated diabetes distress across differing types of technology used, from low-tech to high-tech options, possibly meaning that technology does not add or take away distress. In addition, users on multiple daily injections compared to all other technology groups have less positive attitudes about technology. Finally, we discuss implications for clinical practice and future research.
1型糖尿病患者可以使用新技术来辅助管理。本手稿有两个目的:1)简要回顾关于糖尿病技术使用的文献以及这与心理因素的关系,2)给出一个人为因素研究的例子,利用我们的数据来检验与技术使用相关的心理因素。多年来,设备/技术的采用和使用有所增加,目前这是一种常见的临床实践。在健康和社会心理结果方面存在不同的结果,特定亚组在使用技术方面比其他亚组表现更好。我们的数据表明,从低技术到高技术选项,患者在使用不同类型技术时的糖尿病困扰程度适度升高,这可能意味着技术既不会增加也不会减少困扰。此外,与所有其他技术组相比,每日多次注射的使用者对技术的态度不太积极。最后,我们讨论了对临床实践和未来研究的影响。